Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).
Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS
The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatments based on a patient’s own skin cells for diseases of the central nervous system (CNS).
In MS, the body’s own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.
Key immune cells involved in causing this damage are macrophages (literally ‘big eaters’), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.
Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body’s ‘master cells’, which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) – stem cells that are part-way to developing into nerve cells – reduces inflammation and can help the injured CNS heal.
However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.
A possible solution to this problem would be the use of so-called ‘induced neural stem cells (iNSCs)’ – these cells can be generated by taking an adult’s skin cells and ‘re-programming’ them back to become neural stem cells. As these iNSCs would be the patient’s own, they are less likely to trigger an immune response.
Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.
Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.
Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia – in essence, turning ‘bad’ immune cells ‘good’. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS,” says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.
“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”
The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.
Dr Luca Peruzzotti-Jametti, the first author of the study and a Wellcome Trust Research Training Fellow, says: “We made this discovery by bringing together researchers from diverse fields including regenerative medicine, cancer, mitochondrial biology, inflammation and stroke and cellular reprogramming. Without this multidisciplinary collaboration, many of these insights would not have been possible.”
The Latest on: Personalised stem cell treatment
via Google News
The Latest on: Personalised stem cell treatment
- Star Trek-inspired personalized medicine is on the horizon | Opinionon November 29, 2020 at 10:33 am
This sci-fi precursor is now changing the face of personalized medicine by taking the tricorder ... We are seeking to develop a sensor that could measure the ability of white blood cells to kill the ...
- Stem Cell Medical Research to Expand in California Following Passage of Prop. 14on November 27, 2020 at 9:55 pm
California’s stem cell research agency was supposed to be winding down its operations after a 16-year run, but voters gave it a new lease on life.
- A Perfect Match: Molecular Tests Developed at MSK Guide Personalized Treatment for Lung Canceron November 25, 2020 at 1:23 pm
For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.
- Mapping out the mystery of blood stem cellson November 25, 2020 at 8:10 am
Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughout our life by looking at vast, uncharted regions of our genetic material that hold important ...
- Research topics to expand as California passes stem cell measureon November 24, 2020 at 9:02 pm
By narrowly approving Proposition 14, California voters will infuse researchers with billions more in funding to study some areas that don’t even involve stem cells.
- New nanotechology design provides hope for personalized ‘vaccination’ to treat canceron November 23, 2020 at 11:03 am
Published in Science Advances, a new study by University of Chicago scientists demonstrates a new approach that delivers a one-two punch against cancer cells: using tiny metal-organic frameworks to ...
- Scientists kill cancer cells with ground-breaking DNA-altering treatmenton November 22, 2020 at 7:35 pm
Scientists in Israel have announced a world-first cancer breakthrough, saying they have destroyed cancerous cells in mice using Nobel Prize-winning technology. The CRISPR Cas-9 gene editing system ...
- Israeli scientists kill cancer cells with ground-breaking DNA-altering treatment CRISPRon November 22, 2020 at 12:20 pm
Israeli scientists have used a ground-breaking DNA editing tool to kill cancer cells in animals for the first time. Tel Aviv University scientists hope the treatment could be ready for humans in two ...
- New findings speed progress towards affordable gene therapyon November 20, 2020 at 9:41 am
In a promising advance for affordable, personalized medicine, researchers have used metal-organic frameworks to successfully deliver the genetic snipping tool CRISPR/Cas9 into human cancer cells.
- Revolutionary CRISPR-based genome editing system treatment destroys cancer cellson November 19, 2020 at 4:00 pm
Researchers have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer. The researchers developed a ...
via Bing News